The FDA has given the nod to Abbott's Depakote ER (divalproex sodium) tablets for the treatment of mania or mixed episodes with or without psychotic features associated with bipolar disorder. Depakote ER is the once-daily formulation of Depakote tablets, which has been a treatment for bipolar disorder since its approval in 1995.
Mental Health and CBD: What's the Latest Info
October 27th 2022Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
Promoting Health Equity and Achieving Pharmacoequity to Ensure Medication Access for All
March 27th 2023Speakers at the 2023 virtual Value-Based Insurance Design Summit discussed government programs and company initiatives to advance health equity, as well as the role of research and advocacy to achieve pharmacoequity.
2 Clarke Drive
Cranbury, NJ 08512